New eye drug challenger aims to match leading treatment for blinding condition
Disease control
Completed
This study tested if a new drug called LUBT010 is as effective and safe as the established treatment Lucentis for wet age-related macular degeneration, a major cause of vision loss. About 600 participants aged 50+ with active disease received monthly eye injections of either drug…
Phase: PHASE3 • Sponsor: Lupin Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC